NextCure (NASDAQ:NXTC) Stock Quotes, Forecast and News Summary

Q: What sector and industry does NextCure (NXTC) operate in?

NextCure is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

NextCure Stock (NASDAQ: NXTC) stock price, news, charts, stock research, profile.

Open	$1.71
Close	-
Volume / Avg.	10.19K / 97.94K
Day Range	1.69 - 1.76
52 Wk Range	0.98 - 2.57
Market Cap	$48.11M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	60
Short Interest	0.38%
Days to Cover	1.11

Recent News

Why Amtech Systems Shares Are Trading Higher By Over 30%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Shares of Amtech Systems, Inc. (NASDAQ: ASYS) shares fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter sales results and issued first-quarter sales guidance below estimates.

Avi Kapoor

US Stocks Higher; Initial Jobless Claims Fall To 202,000

U.S. stocks traded higher this morning, following the release of economic reports on Thursday. Following the market opening Thursday, the Dow traded up 0.24% to 37,180.82 while the NASDAQ rose 0.60% to 14,822.95. The S&P 500 also rose, gaining, 0.50% to 4,730.68.

Avi Kapoor

NextCure, LegoChem Biosciences Ink Collaborative Pact For Antibody Drug Conjugates

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Mar

May

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Nextcure Inc

Sector

Health Care

Industry

Biotechnology

NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing n...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy NextCure (NXTC) stock?

You can purchase shares of NextCure (NASDAQ:NXTC) through any online brokerage.

View our list of the best stock brokerages

Who are NextCure (NXTC) competitors?

Other companies in NextCure’s space includes: Kezar Life Sciences (NASDAQ:KZR), Fortress Biotech (NASDAQ:FBIO), Estrella Immunopharma (NASDAQ:ESLA), OncoCyte (NASDAQ:OCX) and CARISMA Therapeutics (NASDAQ:CARM).

What is the target price for NextCure (NXTC) stock?

There is no analysis for NextCure.

What is the forecast for NextCure (NXTC) stock?

NextCure has a consensus price target of $8.25.

Current stock price for NextCure (NXTC)?

The stock price for NextCure (NASDAQ: NXTC) is $1.755 last updated Today at July 17, 2024 at 10:53 AM EDT.

Does NextCure (NXTC) pay a dividend?

There are no upcoming dividends for NextCure.

When is NextCure (NASDAQ:NXTC) reporting earnings?

NextCure’s Q2 earnings are confirmed for Thursday, August 1, 2024.

Is NextCure (NXTC) going to split?

There is no upcoming split for NextCure.

What sector and industry does NextCure (NXTC) operate in?

NextCure is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

NextCure

NextCure (NXTC) Forecast